MRSH

Business profile & competitive position

Marsh & McLennan Companies, Inc. (MRSH) operates in the Financial Services sector, specifically in the Insurance - Brokers industry. It is a global professional-services firm organized around risk, reinsurance, capital, people and investments, and management consulting. According to its most recent 10-K, the company serves clients across 130 countries, generates annual revenue of about $27 billion, and employs more than 95,000 colleagues.

The company reports through two segments. Risk and Insurance Services accounted for approximately 64% of 2025 revenue, or roughly $17.3 billion, with about 55,700 colleagues. Within that segment, Marsh Risk alone produced about 54% of total company revenue, while Guy Carpenter contributed about 10%. The Consulting segment generated approximately 36% of 2025 revenue, or roughly $9.7 billion, with about 29,100 colleagues split between Mercer and Marsh Management Consulting.

The financial profile accompanying that scale is notable: a 14.2% net margin and a 26.5% return on equity. Those figures are consistent with a business that compounds capital efficiently and retains pricing power in its advisory and brokerage relationships. A brokerage-led model also tends to be capital-light compared with underwriting balance sheets, which helps explain why the company can simultaneously support a global footprint, a $692 billion Mercer asset-administration book as of December 31, 2025, and reinvestment in talent and technology without straining returns.

Financial posture

At the snapshot date, the company carried an $88.6 billion market capitalization and traded at a P/E of 22.6. That valuation sits at a premium to many diversified financials, but it is not unusual relative to a high-return, defensive intermediary model. The 14.2% net margin and 26.5% ROE back up the valuation stitch with actual profitability rather than top-line narrative alone.

The beta is 0.58, which is materially below the market beta of 1.0. That low reading fits the steady, fee-and-commission earnings profile of an insurance broker: revenue is recurring, client-switching costs are high, and the business does not take direct underwriting risk. For a stock priced at 22.6 times earnings, the combination of capital-light returns and below-market volatility is part of how the market historically contextualizes the name.

Strategic priorities & outlook

The company's most recent 10-K filing outlines four near-term operational priorities that are likely to shape execution over the next several quarters.

First, Marsh is rolling out an updated corporate brand and aligning Marsh Risk and Marsh Management Consulting under their new names, while Mercer and Guy Carpenter temporarily keep their current brands. Second, management wants to fully realize the opportunities and efficiencies from the Thrive program, which focuses on brand strategy, delivering greater value to clients, accelerating growth and improving efficiency.

Third, the company intends to continue building the Marsh McLennan Agency (MMA) platform, which has acquired more than 135 agencies since 2009. The agenda there is to broaden business insurance, employee health and benefits, retirement, wealth management and private client solutions. Fourth, Marsh is advancing colleague skills and leadership at scale through AI Academies and the leadership Mindset Academy; more than 46,000 colleagues had earned AI Academy credentials since its August 2024 launch.

These priorities point to a strategy that combines brand-led integration, bolt-on distribution expansion through MMA, and workforce productivity improvements via generative AI and leadership training. In 2025, the revenue split of 64% Risk and Insurance Services to 36% Consulting means the success of both sides of the house matters for overall growth.

Macro & geopolitical exposure

As an Insurance - Brokers business within Financial Services, Marsh is exposed to several macro levers. Insurance broking and reinsurance activity are tied directly to commercial property-casualty pricing cycles, regulation of capital requirements and disclosures, and capital-market conditions that influence M&A and initial-public-offering flows. A lighter M&A environment tends to mute Mercer transaction work and consulting demand, while stronger M&A and employment trends support that segment.

Rising healthcare inflation is a specific pressure on Mercer's health and benefits advisory practice, since employers rely on the firm to design and negotiate employee coverage. Cyber risk is another structural tailwind in the risk-and-insurance segment, as corporations buy more coverage and advisory support around data breaches and business interruption. Currency is a background factor as well; with revenue generated across 130 countries, a stronger U.S. dollar can compress translated overseas fees.

Recent developments

Recent news has centered on healthcare costs, cyber offerings, and wage guidance. On September 3, 2026, zacks.com published "How Can Healthcare Inflation Fuel Growth for MRSH, UNH & CNC?", which probed the way rising medical costs can translate into demand for Marsh's advisory services. On September 2, 2026, businesswire.com reported that "Employers Expect Health Benefit Costs to Jump 8.2% in 2027, and the Impact Will Likely Be Felt by Workers, According to Marsh." That figure gives a concrete sense of the pressure driving employer engagement with Mercer's health-benefits consulting.

On September 1, 2026, zacks.com flagged that "Marsh Flags Moderate 2027 Pay Hikes, Launches Cyber Protect in Asia," while gurufocus.com separately announced that Marsh and Resilience had launched Cyber Protect in Asia to help organizations strengthen cyber resilience. The Cyber Protect launch dovetails with the broader cyber-risk exposure theme in Marsh's Risk and Insurance Services segment, while the pay-hike commentary links back to Mercer's human-capital advisory work.

Earnings behavior & post-earnings drift

Marsh has delivered an 8-for-8 beat rate over the last eight reported quarters, with an average earnings surprise of 3.4%. Despite the consistent upside, the average 5-day price move after those reports is only 0.45%, classified as flat. In other words, the market appears to price in strong execution, leaving limited post-earnings drift even when the company beats estimates.

The last four quarters show that dynamic in detail. On July 21, 2026, the company reported EPS of $2.96 versus a $2.88 estimate, a 2.8% beat; the stock fell 3.08% the next day but recovered 5.84% over the following five days. On April 16, 2026, EPS of $3.29 beat the $3.22 estimate by 2.2%, yet the stock dropped 3.71% the next session and 4.69% over five days. On January 29, 2026, EPS of $2.12 was 7.6% above the $1.97 estimate, producing a nearly flat 0.14% next-day move and a -0.22% five-day drift. On October 16, 2025, EPS of $1.85 beat by 3.9%, with the stock rising 1.67% the next day and 0.86% over the following five days.

The next scheduled report is October 15, 2026, before the market opens, with a consensus EPS estimate of $1.96. At the time of the snapshot, the stock traded at $185.74, with an RSI of 45.3 and a 50-day EMA of $184.68.

For a deeper dive, consider looking at the full institutional verdict on MRSH, where you can compare the latest analyst revisions, valuation context, and sector-relative consensus alongside the numbers and developments covered above.